Winter cholecalciferol supplementation at 55°N has little effect on markers of innate immune defense in healthy children aged 4–8 years: a secondary analysis from a randomized controlled trial
- 23 March 2018
- journal article
- research article
- Published by Springer Nature in European Journal of Nutrition
- Vol. 58 (4) , 1453-1462
Abstract
Purpose We explored the effect of winter cholecalciferol (vitamin D3) supplementation on innate immune markers in healthy Danish children (55°N). Methods In the double-blind, placebo-controlled trial, ODIN Junior, 119 healthy, white, 4–8 year-olds were randomized to 0 (placebo), 10 or 20 µg/day of vitamin D3 for 20 weeks (October–March). Cheek mucosal swabs, blood samples, and questionnaires on acute respiratory infections the previous month were collected at baseline and endpoint. Innate immune markers were measured as secondary outcomes including in vivo oral mucosal gene expression of calprotectin (S100A9), lipocalin-2 (LCN2), beta-defensin-4 (DEFB4), interleukin-8 (IL-8), viperin (RSAD2), and the cathelicidin-antimicrobial-peptide (CAMP); ex vivo whole-blood lipopolysaccharide (LPS)-induced cathelicidin, IL-8, and IL-6; and plasma cathelicidin, together with serum 25-hydroxyvitamin D [25(OH)D]. Results Serum 25(OH)D was 56.7 ± 12.3 nmol/L at baseline and 31.1 ± 7.5, 61.8 ± 10.6, and 75.8 ± 11.5 nmol/L at endpoint after placebo, 10 and 20 µg/day of vitamin D3 (P < 0.0001), respectively. A decreased oral mucosal S100A9 expression with placebo [− 18 (95% CI − 1; − 32)%] was marginally avoided with 20 µg/day [6 (− 13; 28)%] (P = 0.06). Likewise, a decreased LPS-induced IL-8 with placebo [− 438 (95% CI − 693; − 184) ng/L] was marginally avoided with 20 µg/day [− 109 (− 374; 157) ng/L] (P = 0.07). All other immune markers and respiratory infection episodes were unaffected by vitamin D3 supplementation (all P > 0.11). Conclusions Winter vitamin D3 supplementation of 10 µg/day did not affect innate immune markers, whereas 20 µg/day tended to maintain the capacity to produce a few markers in healthy children.Keywords
Funding Information
- Lundbeck Foundation (R180-2014-3481)
- Brødrene Hartmanns Fond (A26842)
- Seventh Framework Programme (613877)
This publication has 42 references indexed in Scilit:
- Primary 1,25-Dihydroxyvitamin D3 Response of the Interleukin 8 Gene Cluster in Human Monocyte- and Macrophage-Like CellsPLOS ONE, 2013
- Vitamin d deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot studyJournal of Translational Medicine, 2013
- Effect of Vitamin D Supplementation on Mycobacterium tuberculosis-Induced Innate Immune Responses in a Canadian Dené First Nations CohortPLOS ONE, 2012
- Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1The Journal of Immunology, 2012
- Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adultsJournal of Allergy and Clinical Immunology, 2011
- Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial ResponsesThe Journal of Immunology, 2009
- Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3Journal of Cystic Fibrosis, 2007
- Body mass index cut offs to define thinness in children and adolescents: international surveyBMJ, 2007
- Epidemic influenza and vitamin DEpidemiology and Infection, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001